Key market need Opportunity to expand demand among critical care centers seeking AKI risk mitigation tools; emphasize real-time fluids management and kidney protection as a differentiator.

Growth trajectory Company has grown with funding of $82M and revenue in the low-to-mid eight figures range, signaling potential for larger-scale deployments in hospital systems and academic medical centers.

Leadership transition Recent appointment of a new CEO suggests updated strategy and energy for commercialization; align outreach with his vision and leverage momentum in growth initiatives.

Product differentiation Accuryn Monitoring System turns standard catheters into precision monitoring tools, enabling earlier AKI detection; position as a value driver for ICU protocols and device integration strategies.

Expansion opportunities Post-upgrade activity and Active Drain Line technology present cross-sell or upsell avenues with hospitals upgrading monitoring capabilities; target mid to large hospital networks and affiliated centers.